ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Form Network To Compete For Managed Care, Develop Standards

January 27, 1995

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984